| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.10. | Disclosure of significant shareholding in Atlantic Sapphire ASA | ||
| 18.10. | Atlantic Sapphire ASA: Mandatory notification of trades | ||
| 18.10. | Atlantic Sapphire ASA: Information about the warrants to be listed | ||
| 17.10. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.10.2024 | Das Instrument 4SM NO0010187032 MAGNORA ASA NK 0,50 EQUITY wird cum Kapitalmassnahme gehandelt am 17.10.2024 und ex Kapitalmassnahme am 18.10.2024 The instrument 4SM NO0010187032 MAGNORA ASA NK 0,50... ► Artikel lesen | |
| 16.10. | Atlantic Sapphire ASA: Q3 2024 Trading Update |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | BerGenBio Names New CEO | ||
| Mi | BerGenBio ASA: BerGenBio Appoints Olav Hellebø as CEO | BERGEN, Norway, Nov. 20, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical... ► Artikel lesen | |
| 13.11. | BerGenBio ASA: BerGenBio Third Quarter Results 2024 | BERGEN, Norway, Nov. 13, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharma-ceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical... ► Artikel lesen | |
| 06.11. | BerGenBio ASA: Invitation to third quarter 2024 results webcast | ||
| 10.10. | BERGENBIO ASA: CEO Martin Olin steps down |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | BioCardia-CEO Peter Altman erwirbt Stammaktien im Wert von 2.524 US-Dollar | ||
| 15.11. | BioCardia stock plunges to 52-week low, touches $1.93 | ||
| 13.11. | BioCardia GAAP EPS of -$0.61 beats by $0.58 | ||
| 29.10. | Lantion out as Marcos names Paredes new BCDA chairman | ||
| 28.10. | BioCardia, Inc.: BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure | SUNNYVALE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.11. | Spotlight Stock Market: Market Notice 232/24- Last day of trading in WntResearch AB's subscription option WNT TO 7 | ||
| 17.10. | WntResearch updates after stopped study | ||
| 09.10. | Spotlight Stock Market: Market notice 196/24 - WntResearch AB's share WNT is moved to the Observation List | ||
| 09.10. | WntResearch provides an update on the work in progress to safeguard the interests of shareholders and company values | ||
| 20.09. | WntResearch plummets after results |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ATLANTIC SAPPHIRE ASA | 0,017 | +745,00 % |
| BERGENBIO ASA | 0,849 | -3,19 % |
| BIOCARDIA INC | 2,260 | +5,85 % |
| WNTRESEARCH AB | 1,075 | 0,00 % |
